Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 62 (82) , S81-S87
- https://doi.org/10.1046/j.1523-1755.62.s82.16.x
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Sirolimus: a comprehensive reviewExpert Opinion on Pharmacotherapy, 2001
- Immunosuppressive medications for renal transplantation: A multiple choice questionKidney International, 2001
- DOUBLE-BLIND COMPARISON OF TWO CORTICOSTEROID REGIMENS PLUS MYCOPHENOLATE MOFETIL AND CYCLOSPORINE FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1Transplantation, 2000
- Cyclosporin-Induced HypertensionDrug Safety, 1999
- LOW-DOSE CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH SUBOPTIMAL RENAL FUNCTION1,2Transplantation, 1998
- ROLE OF STEROID DOSE IN HYPERTENSION EARLY AFTER LIVER TRANSPLANTATION WITH TACROLIMUS (FK506) AND CYCLOSPORINE1Transplantation, 1996
- Effects of an Endothelin Receptor Antagonist in Rats With Cyclosporine-Induced HypertensionHypertension, 1995
- Rapamycin: A novel immunosuppressive macrolideMedicinal Research Reviews, 1994
- RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENTTransplantation, 1991
- CyclosporineNew England Journal of Medicine, 1989